 |  |  |
| PHIN2029-2 | Regulation and the medical-social environment - Aspects économiques du développement du médicament - Legislation and procedures applied to pharmaceutical industry, part a : legislation - Legislation and procedures applied to pharmaceutical industry, part b : patents and protection - Environnment macro-économique et pharmaco-économie - CTD File (Common Technical Document) - Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files - Regulations of preclinical and clinical studies, part b : clinical studies - Regulations of preclinical and clinical studies, part c : pediatric studies - Specific regulatory issues, part a : medicine and herbal dietary supplement - Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique
|

 |
| Duration : | Aspects économiques du développement du médicament : 10h Th Legislation and procedures applied to pharmaceutical industry, part a : legislation : 10h Th, 5h Pr Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : 5h Th Environnment macro-économique et pharmaco-économie : 10h Th CTD File (Common Technical Document) : 15h Th Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : 15h Th Regulations of preclinical and clinical studies, part b : clinical studies : 5h Th Regulations of preclinical and clinical studies, part c : pediatric studies : 2,5h Th Specific regulatory issues, part a : medicine and herbal dietary supplement : 5h Th Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique : 5h Th
|
 |
| Number of credits : |
|
 |
| Lecturer : | Aspects économiques du développement du médicament : Dominique Martin
Legislation and procedures applied to pharmaceutical industry, part a : legislation : Catherine Druez
Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : Patrick Di Stefano
Environnment macro-économique et pharmaco-économie : Alain De Wever
CTD File (Common Technical Document) : Jean‑Antoine De Muylder
Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : Sonia Beken
Regulations of preclinical and clinical studies, part b : clinical studies : A Lenaers
Regulations of preclinical and clinical studies, part c : pediatric studies : Daniel Brasseur
Specific regulatory issues, part a : medicine and herbal dietary supplement : Monique Tits
Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique : Francis Verbist
|
 |
| Coordinator : | Philippe Hubert |
 |
Language(s) of instruction :
 |
| French language |
 |

|
|  |